Daily Medication Pearl: Fluticasone/Salmeterol (Wixela)


Wixela Inhub is indicated for the treatment of asthma in patients 4 years of age and older and maintenance treatment of patients with chronic obstructive pulmonary disease.

Medication Pearl of the Day: Fluticasone/salmeterol (Wixela)

Indication: Wixela Inhub is a combination product containing a corticosteroid and a long-acting beta2-adrenergic agonist (LABA) indicated for the treatment of asthma in patients 4 years of age and older. Maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).


  • Dosing: For oral inhalation only. Asthma—1 inhalation of Wixela 100/50, 250/50, or 500/50 twice daily. Starting dosage is based on asthma severity. Maintenance treatment of COPD—1 inhalation of Wixela Inhub 250/50 twice daily.
  • Dosage forms: Inhaler containing a combination of fluticasone propionate (100, 250, or 500 mcg) and salmeterol (50 mcg) as a powder formulation for oral inhalation.
  • Adverse events: Upper respiratory tract infection or inflammation, pharyngitis, dysphonia, oral candidiasis, bronchitis, cough, headaches, nausea, and vomiting.
  • Mechanism of action: Fluticasone propionate is a synthetic trifluorinated corticosteroid with anti-inflammatory activity. Salmeterol is a selective long-acting beta adrenergic agonist.
  • Manufacturer: Mylan


Related Videos
Pride flags during pride event -- Image credit: ink drop | stock.adobe.com
Female Pharmacist Holding Tablet PC - Image credit: Tyler Olson | stock.adobe.com
African American male pharmacist using digital tablet during inventory in pharmacy - Image credit: sofiko14 | stock.adobe.com
Young woman using smart phone,Social media concept. - Image credit: Urupong | stock.adobe.com
selling mental health medication to man at pharmacy | Image Credit: Syda Productions - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Image credit: rawpixel.com | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.